0000899243-17-026032.txt : 20171113 0000899243-17-026032.hdr.sgml : 20171110 20171113162606 ACCESSION NUMBER: 0000899243-17-026032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171113 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morningside Venture Investments Ltd CENTRAL INDEX KEY: 0001543112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 171196246 BUSINESS ADDRESS: STREET 1: MCCARTHY LEGAL SERVICES STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 BUSINESS PHONE: 617-244-2800 MAIL ADDRESS: STREET 1: MCCARTHY LEGAL SERVICES STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 BUSINESS PHONE: 502-241-4114 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-13 0 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001543112 Morningside Venture Investments Ltd 2ND FLOOR, LE PRINCCE DE GALLES 3-5 AVENUE DES CITRONNIERS MC 98000 O9 MONACO 0 0 1 0 Common Stock 2017-11-13 4 C 0 10778303 A 10778303 D Common Stock 2017-11-13 4 P 0 575000 14.00 A 11353303 D Series B Preferred Stock 2017-11-13 4 C 0 1054544 0.00 D Common Stock 494394 0 D Series C Preferred Stock 2017-11-13 4 C 0 17200000 0.00 D Common Stock 8063759 0 D Series D Preferred Stock 2017-11-13 4 C 0 4476275 0.00 D Common Stock 2098581 0 D Series E Preferred Stock 2017-11-13 4 C 0 259302 0.00 D Common Stock 121566 0 D The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. /s/ Louise Mary Garbarino 2017-11-13 /s/ Jill Marie Franklin 2017-11-13